Related Experiment Video
Updated: Jan 10, 2026
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
Published on: March 23, 2022
Repeated-dose behavioral intervention to reduce opioid overdose among overdose survivors with opioid use disorder: A
Phillip O Coffin1,2, Glenn-Milo Santos1,2, Vanessa M McMahan1
1Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
Background And Aims:
The emergence of fentanyl in the street market for opioids has limited the benefits of some interventions to manage opioid overdose; thus, preventing the occurrence of opioid overdose is essential. We tested a behavioral intervention shown to prevent heroin overdose in a pilot study, in two United States cities with prevalent fentanyl.
Design:
Phase III two-site single-blinded randomized controlled trial of a repeated dose motivational interviewing intervention to reduce overdose (REBOOT) versus attention control, over 16 months from 2019 to 2023.
Setting:
San Francisco, California, and Boston, Massachusetts, USA.
Participants:
18-65 years of age, with opioid use disorder (OUD), active non-prescribed opioid use, opioid overdose within 3 years and prior receipt of take-home naloxone. A total of 268 participants were randomized (50% intervention, 50% control), 62% of whom were male, 15% Latine, 65% White and 14% Black/African American; 95% had used fentanyl.
Intervention:
Motivational interviewing review of experienced and witnessed overdose and development of personal prevention plan, administered at months 0, 4, 8 and 12.
Measurements:
TimeLine FollowBack of interval overdose events and covariates, administered prior to the intervention at months 0, 4, 8, 12 and 16. Primary outcome was occurrence of any nonfatal or fatal overdose event.
Findings:
There were no significant effects of REBOOT compared with control on the primary outcome of occurrence of any overdose [relative risk (RR) = 0.94, 95% confidence interval (CI) = 0.79-1.11, P = 0.45] or secondary outcome of the number of overdose events (RR = 0.80, 95% CI = 0.6-1.06, P = 0.12). Results did not differ when excluding data collected during the first 12 months of the COVID-19 pandemic. Compared with control, REBOOT was not associated with days in OUD treatment and not using opioids (RR = 0.94, 95% CI = 0.88-1.00, P = 0.06). In post-hoc analysis, REBOOT was associated with fewer overdose events among participants with no past 4-month overdose at baseline (RR = 0.70, 95% CI = 0.51-0.97, P = 0.03).
Conclusion:
A repeated dose motivational interviewing intervention to reduce overdose had no statistically significant effect on opioid overdose in two US cities where fentanyl was the dominant street opioid.
More Related Videos
10:35A Procedure to Study the Effect of Prolonged Food Restriction on Heroin Seeking in Abstinent Rats
Published on: November 11, 2013
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:16Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:21Drug Dosing: Obese Patients